Evidence map›Paper›PMID 34444579›Full record

Observational studyInternational journal of environmental research and public health2021

Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain.

Carolina Lechosa-Muñiz, María Paz-Zulueta, Jose Manuel Mendez-Legaza, Juan Irure-Ventura, Rocío Cuesta González, Jorge Calvo Montes, Marcos López-Hoyos, Javier Llorca, María Jesús Cabero-Pérez

Abstract readObservational Study
In one paragraph

Observational study in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carolina Lechosa-MuñizFaculty of Nursing, University of Cantabria, Avda Valdecilla s/n. C.P., 39008 Santander, Cantabria, Spain.
María Paz-ZuluetaFaculty of Nursing, University of Cantabria, Avda Valdecilla s/n. C.P., 39008 Santander, Cantabria, Spain.ORCID 0000-0003-3201-5488
Jose Manuel Mendez-LegazaDepartment of Microbiology, Hospital Universitario Marqués de Valdecilla, C.P., 39008 Santander, Cantabria, Spain.
Juan Irure-VenturaDepartment of Immunology, Hospital Universitario Marqués de Valdecilla, IDIVAL, C.P., 39008 Santander, Cantabria, Spain.ORCID 0000-0003-2315-8671
Rocío Cuesta GonzálezDepartment of Pediatrics, Hospital Universitario Marqués de Valdecilla, C.P., 39008 Santander, Cantabria, Spain.
Jorge Calvo MontesDepartment of Microbiology, Hospital Universitario Marqués de Valdecilla, C.P., 39008 Santander, Cantabria, Spain.ORCID 0000-0003-2898-6599
Marcos López-HoyosDepartment of Immunology, Hospital Universitario Marqués de Valdecilla, IDIVAL, C.P., 39008 Santander, Cantabria, Spain.ORCID 0000-0003-0562-427X
Javier LlorcaFaculty of Medicine, University of Cantabria, Avenida del Cardenal Herrera Oria 2, C.P., 39010 Santander, Cantabria, Spain.
María Jesús Cabero-PérezFaculty of Medicine, University of Cantabria, Avenida del Cardenal Herrera Oria 2, C.P., 39010 Santander, Cantabria, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breastfeeding mothers were excluded from the clinical trials conducted for vaccines against SARS-CoV-2. Since the start of the vaccination, some doubts have arisen regarding its compatibility with breastfeeding. The aim of this study was to analyse the presence of anti-SARS-CoV-2 antibodies in breast milk and serum (IgG and IgA) of vaccinated breastfeeding women. The main variables of the observational study were: adverse related events after vaccination and determination of the presence of IgG and IgA isotypes antibodies in serum and in breast milk of vaccinated women against the SARS-CoV-2 antigens. Results: 110 breastfeeding mothers were included; 70 women (63.6%) were vaccinated with two doses of BNT162b2, 20 women (18.2%) with two doses of mRNA-1273, and 20 women (18.2%) with a single dose of ChAdOx1-S. Regarding adverse reactions and vaccine safety, 38 women had no adverse reactions; 20 (18.2%) had general malaise or adenopathies; 10 (9.1%) had a headache; and 7 (6.4%) had fever. When analysing IgG antibodies, significantly higher levels of antibodies were found in serum and breast milk from mothers vaccinated with BNT162b2 or mRNA-1273 vs. ChAdOx1-S (

Indexed as

COVID-19COVID-19 VaccinesBNT162 VaccineBreast FeedingCross-Sectional StudiesFemaleHumansImmunoglobulin AImmunoglobulin GMilk, HumanSARS-CoV-2SpainBNT162 VaccineCOVID-19 VaccinesImmunoglobulin AImmunoglobulin Gantibodiesbreastfeedingbreast milkCOVID-19 vaccinematernal immunityneonatal immunity

Identifiers

PMID34444579
PMCPMC8393848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.